Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1038/ncb781

http://scihub22266oqcxt.onion/10.1038/ncb781
suck pdf from google scholar
11941371!ä!11941371

Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=11941371&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215

suck abstract from ncbi


Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\11941371.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117
pmid11941371      Nat+Cell+Biol 2002 ; 4 (5): 329-36
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • The TRPM7 channel is inactivated by PIP(2) hydrolysis #MMPMID11941371
  • Runnels LW; Yue L; Clapham DE
  • Nat Cell Biol 2002[May]; 4 (5): 329-36 PMID11941371show ga
  • TRPM7 (ChaK1, TRP-PLIK, LTRPC7) is a ubiquitous, calcium-permeant ion channel that is unique in being both an ion channel and a serine/threonine kinase. The kinase domain of TRPM7 directly associates with the C2 domain of phospholipase C (PLC). Here, we show that in native cardiac cells and heterologous expression systems, G alpha q-linked receptors or tyrosine kinase receptors that activate PLC potently inhibit channel activity. Numerous experimental approaches demonstrated that phosphatidylinositol 4,5-bisphosphate (PIP(2)), the substrate of PLC, is a key regulator of TRPM7. We conclude that receptor-mediated activation of PLC results in the hydrolysis of localized PIP(2), leading to inactivation of the TRPM7 channel.
  • |*Membrane Proteins[MESH]
  • |Animals[MESH]
  • |Carbachol/pharmacology[MESH]
  • |Cell Line[MESH]
  • |Cholinergic Agonists/pharmacology[MESH]
  • |Diglycerides/pharmacology[MESH]
  • |Heart/drug effects[MESH]
  • |Humans[MESH]
  • |Hydrolysis[MESH]
  • |Ion Channels/*metabolism[MESH]
  • |Models, Biological[MESH]
  • |Myocardium/cytology[MESH]
  • |Patch-Clamp Techniques[MESH]
  • |Phosphatidylinositol 4,5-Diphosphate/*metabolism[MESH]
  • |Protein Kinase C/metabolism[MESH]
  • |Protein Kinases/*metabolism[MESH]
  • |Protein Serine-Threonine Kinases[MESH]
  • |Protein Structure, Tertiary[MESH]
  • |Rats[MESH]
  • |Receptor, Muscarinic M1[MESH]
  • |Receptors, Muscarinic/metabolism[MESH]
  • |Recombinant Fusion Proteins/metabolism[MESH]
  • |TRPM Cation Channels[MESH]
  • |Two-Hybrid System Techniques[MESH]
  • |Type C Phospholipases/*metabolism[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box